The 36-month beta value for SURG is also noteworthy at 1.44. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for SURG is 13.95M, and at present, short sellers hold a 2.87% of that float. The average trading volume of SURG on March 14, 2025 was 149.51K shares.
SURG) stock’s latest price update
Surgepays Inc (NASDAQ: SURG) has experienced a decline in its stock price by -11.63 compared to its previous closing price of 1.29. However, the company has seen a fall of -10.94% in its stock price over the last five trading days. prnewswire.com reported 2025-03-11 that BARTLETT, Tenn., March 11, 2025 /PRNewswire/ — SurgePays, Inc. (NASDAQ: SURG) (“SurgePays” or the “Company”), a technology and telecommunications company, will release its fourth quarter and full year 2024 financial results and Form 10K, after the close of trading on Tuesday, March 25, 2025.
SURG’s Market Performance
Surgepays Inc (SURG) has experienced a -10.94% fall in stock performance for the past week, with a -19.15% drop in the past month, and a -39.68% drop in the past quarter. The volatility ratio for the week is 11.04%, and the volatility levels for the past 30 days are at 8.83% for SURG. The simple moving average for the past 20 days is -12.64% for SURG’s stock, with a -45.13% simple moving average for the past 200 days.
SURG Trading at -22.41% from the 50-Day Moving Average
After a stumble in the market that brought SURG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.23% of loss for the given period.
Volatility was left at 8.83%, however, over the last 30 days, the volatility rate increased by 11.04%, as shares sank -19.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.70% lower at present.
During the last 5 trading sessions, SURG fell by -10.94%, which changed the moving average for the period of 200-days by -70.62% in comparison to the 20-day moving average, which settled at $1.3050. In addition, Surgepays Inc saw -35.96% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SURG starting from Cox Kevin Brian, who sale 35,180 shares at the price of $1.82 back on Dec 03 ’24. After this action, Cox Kevin Brian now owns 5,770,090 shares of Surgepays Inc, valued at $64,084 using the latest closing price.
Evers Anthony George, the Chief Financial Officer of Surgepays Inc, sale 36,666 shares at $1.86 during a trade that took place back on Dec 02 ’24, which means that Evers Anthony George is holding 214,924 shares at $68,199 based on the most recent closing price.
Stock Fundamentals for SURG
Current profitability levels for the company are sitting at:
- -0.27 for the present operating margin
- 0.05 for the gross margin
The net margin for Surgepays Inc stands at -0.27. The total capital return value is set at -0.62. Equity return is now at value -80.54, with -54.04 for asset returns.
Based on Surgepays Inc (SURG), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -2.55. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -47.04.
Currently, EBITDA for the company is 20.08 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 0.17. The receivables turnover for the company is 55.22for trailing twelve months and the total asset turnover is 2.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.24.
Conclusion
In summary, Surgepays Inc (SURG) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
